Homology Medicines, Inc. IPO Research Information

Homology Medicines, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Homology Medicines, Inc. , and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Homology Medicines, Inc.	FIXX - NASDAQ	$14.00-$16.00	$16.00	$23.00	9 million	3/28/2018
Underwriter(s): BofA Merrill Lynch, Cowen, Evercore ISI
Co-Manager(s): BTIG
Industry: Health Care
Filing(s): Filed 2018-03-02 Terms Added 2018-03-19 Amended Prospectus 2018-03-27 Final Prospectus 2018-03-29

Homology Medicines, Inc. Quote & Chart - Click for current quote - FIXX

About Homology Medicines, Inc. (adapted from Homology Medicines, Inc. prospectus):
They are a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "FIXX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.